Business Description
Icecure Medical Ltd
ISIN : IL0011224156
Description
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.96 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -6.17 | |||||
| Beneish M-Score | -3.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -32 | |||||
| 3-Year EBITDA Growth Rate | -12 | |||||
| 3-Year EPS without NRI Growth Rate | -13.3 | |||||
| 3-Year FCF Growth Rate | -7.7 | |||||
| 3-Year Book Growth Rate | -1.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 45.56 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -6.47 | |||||
| 12-1 Month Momentum % | -30.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.67 | |||||
| Quick Ratio | 2.27 | |||||
| Cash Ratio | 2.14 | |||||
| Days Inventory | 387.66 | |||||
| Days Sales Outstanding | 16.56 | |||||
| Days Payable | 149.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31.3 | |||||
| Shareholder Yield % | -17.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.67 | |||||
| Operating Margin % | -397.33 | |||||
| Net Margin % | -376.85 | |||||
| FCF Margin % | -293.96 | |||||
| ROE % | -116.73 | |||||
| ROA % | -83.82 | |||||
| ROIC % | -209.23 | |||||
| ROC (Joel Greenblatt) % | -388.34 | |||||
| ROCE % | -119.92 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.52 | |||||
| PB Ratio | 4.4 | |||||
| Price-to-Tangible-Book | 4.48 | |||||
| EV-to-EBIT | -2.38 | |||||
| EV-to-EBITDA | -2.44 | |||||
| EV-to-Revenue | 9.47 | |||||
| EV-to-Forward-Revenue | 9.8 | |||||
| EV-to-FCF | -3.22 | |||||
| Price-to-Net-Current-Asset-Value | 5.38 | |||||
| Price-to-Net-Cash | 8.03 | |||||
| Earnings Yield (Greenblatt) % | -42.02 | |||||
| FCF Yield % | -24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Icecure Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 13.271 | ||
| EPS (TTM) (₪) | 0 | ||
| Beta | 0 | ||
| Volatility % | 58.74 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (₪) | 0.149929 | ||
| 20-Day SMA (₪) | 0 | ||
| 12-1 Month Momentum % | -30.83 | ||
| 52-Week Range (₪) | 3.34 - 14.97 | ||
| Shares Outstanding (Mil) | 45.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Icecure Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Icecure Medical Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Icecure Medical Ltd Frequently Asked Questions
What is Icecure Medical Ltd(XTAE:ICCM)'s stock price today?
The current price of XTAE:ICCM is ₪4.25. The 52 week high of XTAE:ICCM is ₪14.97 and 52 week low is ₪3.34.
When is next earnings date of Icecure Medical Ltd(XTAE:ICCM)?
The next earnings date of Icecure Medical Ltd(XTAE:ICCM) is 2025-04-03 Est..
Does Icecure Medical Ltd(XTAE:ICCM) pay dividends? If so, how much?
Icecure Medical Ltd(XTAE:ICCM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers